A rare case of ovarian pathology: diffuse large B cell lymphoma of over

Öz

Primary ovarian non-Hodgkin lymphoma is a challenging diagnosis due to its rarity, often leading to delayed treatment, wrong diagnosis, and inappropriate therapy. The patient in this case presentation presented with abdominal pain as the initial symptom. Subsequent abdominal computed tomography revealed a bilateral heterogeneous ovarian mass measuring approximately 6x10x10 cm on the left side and 14x10x7 cm on the right side. An intestinal mass lesion was observed in the ileal ans, causing diffuse wall thickening of ~2 cm at its widest point and focal lumen widening in an ~11 cm segment (lymphoma?). A transvaginal ultrasound was also performed, revealing two cystic masses, one measuring 10 cm and the other 12 cm, with dense and heterogeneous contents filling the uterine cavity and pelvis. Subsequently, a total abdominal hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic lymph node dissection, and small bowel resection and anastomosis were performed.

Anahtar Kelimeler

• Ovarian lymphoma
• double expressor lymphoma
• diffuse large B cell lymphoma

Nadir bir yumurtalık patolojisi vakası: overin yaygın büyük B hücreli lenfoması

Öz

Primer over non-Hodgkin lenfoma, nadir görülmesi nedeniyle tanı koyması zor bir hastalıktır ve sıklıkla tedavinin gecikmesine, yanlış tanıya ve uygun olmayan tedaviye yol açar. Bu vaka sunumundaki hasta, ilk semptom olarak karın ağrısı ile başvurmuştur. Daha sonra yapılan karın bilgisayarlı tomografide, sol tarafta yaklaşık 6x10x10 cm ve sağ tarafta 14x10x7 cm boyutlarında bilateral heterojen over kitlesi saptanmıştır. Ileal ans'ta bağırsak kitlesi lezyonu gözlendi; bu lezyon, en geniş noktasında ~2 cm'lik yaygın duvar kalınlaşmasına ve ~11 cm'lik bir segmentte fokal lümen genişlemesine neden oluyordu (lenfoma?). Transvajinal ultrason da yapıldı ve uterus boşluğunu ve pelvisi dolduran yoğun ve heterojen içerikli, biri 10 cm, diğeri 12 cm boyutlarında iki kistik kitle saptandı. Ardından, total abdominal histerektomi, bilateral salpingo-ooforektomi, bilateral pelvik lenf nodu diseksiyonu ve ince bağırsak rezeksiyonu ve anastomoz yapıldı.

Anahtar Kelimeler

• Yumurtalık lenfoması
• çift ekspresyonlu lenfoma
• yaygın büyük B hücreli lenfoma

Kaynakça

1. Takeuchi T, Yamaguchi M, Kobayashi K, et al. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. Cancer. 2017;123(7):1166-1173. doi:10.1002/cncr.30404
2. AlShemmari SH, Ameen RM, Sajnani KP. Extranodal lymphoma: a comparative study. Hematology. 2008;13(3):163-169. doi:10.1179/102453308X316149
3. Yun J, Kim SJ, Won JH, et al. Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report. Leuk Res. 2010;34(9):1175-1179. doi:10.1016/j.leukres.2010.02.010
4. Kumar N, Kumar R, Bera A, Srinivasan R, Sharma SC. Primary ovarian lymphoma: a case report and review of literature. J Obstet Gynaecol India. 2014;64(1):65-67. doi:10.1007/s13224-012-0200-6
5. Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ. Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases. Am J Surg Pathol. 1993;17(2):154-170. doi:10.1097/00000478-199302000-00007
6. Dimopoulos MA, Daliani D, Pugh W, Gershenson D, Cabanillas F, Sarris AH. Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy. Gynecol Oncol. 1997;64(3):446-450. doi:10.1006/gyno.1996.4583,
7. Gök S, Alataş E, Düzcan E. Overin nadir tümörü: sklerozan stromal tümör. Pam Tıp Derg. 2020;13(2):449-452. doi:10.31362/patd.670426
8. Onyiuke I, Kirby AB, McCarthy S. Primary gynecologic lymphoma: imaging findings. AJR Am J Roentgenol. 2013;201(4):W648-W655. doi:10.2214/AJR.12.8907

9. Crawshaw J, Sohaib SA, Wotherspoon A, Shepherd JH. Primary non-Hodgkin's lymphoma of the ovaries: imaging findings. Br J Radiol. 2007;80(956):e155-e158. doi:10.1259/bjr/35049074
10. Mondal SK, Bera H, Mondal S, Samanta TK. Primary bilateral ovarian Burkitt's lymphoma in a six-year-old child: report of a rare malignancy. J Cancer Res Ther. 2014;10(3):755-757. doi:10.4103/0973-1482.136026
11. Crasta JA, Vallikad E. Ovarian lymphoma. Indian J Med Paediatr Oncol. 2009;30(1):28-30. doi:10.4103/0971-5851.56333
12. Miyazaki K, Yamaguchi M, Suzuki R, et al. CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. Ann Oncol. 2011;22(7):1601-1607. doi:10.1093/annonc/mdq627
13. Oki Y, Noorani M, Lin P, et al. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol. 2014;166(6):891-901. doi:10.1111/bjh.12982
14. Howlett C, Snedecor SJ, Landsburg DJ, et al. Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis. Br J Haematol. 2015;170(4):504-514. doi:10.1111/bjh.13463
15. Dunleavy K, Fanale MA, Abramson JS, et al. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. Lancet Haematol. 2018;5(12):e609-e617. doi:10.1016/S2352-3026(18)30177-7
16. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390. doi:10.1182/blood-2016-01-643569